Sign in Register

Bivalirudin-0.9% Nacl (bivalirudin in 0.9 % sodium chloride)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Generic name: bivalirudin in 0.9 % sodium chloride

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Bivalirudin-0.9% Nacl

Intelligence content is not available yet.

Indications

The following indications are listed for Bivalirudin-0.9% Nacl:

  • Percutaneous Coronary Intervention Adjunct For Thrombosis Prevention
  • Thrombosis Prevention During Percutaneous Coronary Intervention In Heparin-Induced Thrombocytopenia
  • Thrombosis With Heparin-Induced Thrombocytopenia During Percutaneous Coronary Intervention

Also known as: Heparin-Induced Thrombotic Thrombocytopenia During Percutaneous Coronary Intervention, Thrombosis In Heparin-Induced Thrombopenia During Percutaneous Coronary Intervention, Thrombosis Prophylaxis During Percutaneous Coronary Intervention In Heparin-Induced Thrombocytopenia, White Clot Syndrome During Percutaneous Coronary Intervention, White-Clot Syndrome During Percutaneous Coronary Intervention.

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a 5-digit ZIP code. Searching does not change your profile.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data